Vogel A M, Lennon D R, Harding J E, Pinnock R E, Graham D A, Grimwood K, Pattemore P K
Department of Paediatrics, South Auckland Clinical School, University of Auckland, Starship Children's Hospital, Auckland, New Zealand.
J Paediatr Child Health. 2003 Jan-Feb;39(1):40-5. doi: 10.1046/j.1440-1754.2003.00069.x.
To determine the current management of bronchiolitis by five major New Zealand hospitals and to identify areas for improvement.
Lists of infants under 1 year of age admitted with bronchiolitis during 1998 were obtained from the casemix offices of the five largest New Zealand hospitals with paediatric services. Hospital records from a random sample of these admissions were reviewed.
Out of the 409 infants admitted overnight, 8% had been born less than or=32 weeks gestation and 53% were aged younger than 6 months. Overall, 59% received oxygen, 21% had nasogastric fluids, 22% had intravenous fluids, 34% were prescribed antibiotics, 42% received bronchodilators and 60% had a chest radiograph. Respiratory secretions were collected for viral studies from 58% of infants and, in 59%, respiratory syncytial virus was detected. Significant variations in management were detected between hospitals. The overall proportion of infants requiring oxygen, intravenous or nasogastric fluids (65%) was significantly higher than that found in a 1986-1988 Christchurch study where only 25% received one or more of these interventions (P < 0.001).
Opportunities exist to rationalize bronchiolitis management in New Zealand with potential cost savings, particularly by reducing the number of chest radiographs and prescribing of unnecessary antibiotics and bronchodilators.
确定新西兰五家主要医院对细支气管炎的当前管理方式,并找出可改进的方面。
从新西兰提供儿科服务的五家最大医院的病例组合办公室获取1998年因细支气管炎入院的1岁以下婴儿名单。对这些入院病例的随机样本的医院记录进行了审查。
在409名夜间入院的婴儿中,8%的婴儿出生时孕周小于或等于32周,53%的婴儿年龄小于6个月。总体而言,59%的婴儿接受了氧气治疗,21%的婴儿接受了鼻饲液,22%的婴儿接受了静脉输液,34%的婴儿使用了抗生素,42%的婴儿接受了支气管扩张剂治疗,60%的婴儿进行了胸部X光检查。58%的婴儿采集了呼吸道分泌物进行病毒研究,其中59%检测出呼吸道合胞病毒。各医院之间在管理方面存在显著差异。需要氧气、静脉或鼻饲液治疗的婴儿总体比例(65%)显著高于1986 - 1988年克赖斯特彻奇研究中的比例,当时只有25%的婴儿接受了上述一种或多种干预措施(P < 0.001)。
新西兰存在使细支气管炎管理合理化的机会,有可能节省成本,特别是通过减少胸部X光检查的次数以及不必要的抗生素和支气管扩张剂的使用。